SPCC757.11c Antibody

Shipped with Ice Packs
In Stock

Description

Absence of Direct References to SPCC757.11c

A comprehensive review of the provided sources—spanning peer-reviewed articles, patents, and commercial antibody documentation—reveals no direct mention of "SPCC757.11c Antibody." This includes:

  • Search Results1–8: These focus on antibodies targeting CD117, CD11c, mutant p53, or CD7, but none describe an antibody designated as "SPCC757.11c."

Nomenclature Considerations

  • Typographical Error: The designation "SPCC757.11c" may contain a typographical error. For example:

    • CD11c Antibodies: Multiple CD11c-targeting antibodies are documented (e.g., Clone ICRF 3.9 , Clone EP1347Y , Clone HL3 ). These target integrin αX (CD11c), a marker for dendritic cells and myeloid subsets.

    • Clone Numbering: The "757.11c" suffix might refer to a clone ID, but no matches exist in the reviewed literature.

Hypothetical Context

If "SPCC757.11c" refers to a novel, unpublished antibody, its characteristics would require validation through primary research. Key attributes of analogous antibodies include:

AntibodyTargetCloneApplicationsKey Findings
Anti-CD11c [ICRF 3.9]CD11cICRF 3.9Flow cytometry Validated in human PBMCs
Anti-CD11c [EP1347Y]CD11cEP1347YWB, IHC, IP Detects 127–150 kDa bands in AML cells
Anti-CD7 ADCCD7N/AT-cell leukemia therapy Induces cytotoxicity via MMAE payload

Recommendations for Further Inquiry

  1. Primary Literature Search: Use databases like PubMed or Google Scholar with precise search terms (e.g., "SPCC757.11c Antibody," "Clone 757.11c").

  2. Commercial Catalogs: Check antibody vendors (e.g., R&D Systems, Abcam) for unreleased products.

  3. Patent Databases: Explore USPTO or WIPO for pending patents related to this designation.

Limitations of Current Data

The absence of "SPCC757.11c" in the provided sources underscores the need for caution. Claims about its specificity, structure, or applications cannot be substantiated without direct evidence.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01 M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPCC757.11c antibody; Uncharacterized MFS-type transporter C757.11c antibody
Target Names
SPCC757.11c
Uniprot No.

Target Background

Database Links
Protein Families
Major facilitator superfamily
Subcellular Location
Golgi apparatus. Membrane; Multi-pass membrane protein.

Q&A

What is the SPCC757.11c protein and why is an antibody against it valuable for research?

SPCC757.11c is a protein in Schizosaccharomyces pombe (fission yeast). While specific information about this particular protein is limited in the search results, the nomenclature follows the standard S. pombe genome annotation system where SPCC indicates chromosome location, and the subsequent numbers represent specific coordinates. Antibodies against such proteins are valuable for studying protein expression, localization, interactions, and function in fundamental cellular processes. Similar approaches have been successfully used with other yeast proteins such as those studied in transcription regulation research, as seen with the Atf1 and Pcr1 transcription factors .

How should researchers validate the specificity of SPCC757.11c antibodies?

Antibody validation should follow a multi-step approach similar to that used for other research antibodies. From the methodology described for monoclonal antibodies in search result , researchers should:

  • Perform immunolabeling reactions with both positive and negative controls

  • Conduct FACS analyses to confirm binding specificity

  • Evaluate cross-reactivity with related proteins

  • Verify specificity through knockdown or knockout of the target protein

  • Compare results with alternative detection methods (Western blot, immunoprecipitation)

As described in the validation process for other antibodies, "cells were labeled for 30 minutes with hybridoma supernatants or purified mAbs... both singly and in combination with other cell-surface markers... Cells were next washed in FACS buffer and incubated for 30 minutes with conjugated fluorophore isotype matched secondary antibodies" .

What controls should be included when using SPCC757.11c antibodies in experiments?

Based on standard antibody research protocols and the methodologies mentioned in search results, researchers should include:

  • Isotype controls (matched to the antibody class and species)

  • Secondary antibody-only controls

  • Known positive and negative cell/tissue samples

  • Competitive inhibition controls where applicable

  • Genetic controls (e.g., SPCC757.11c knockout or knockdown strains)

For immunofluorescence experiments, similar to those conducted with stem cell antibodies, "For OCT4 multicolor analyses, cells were sequentially live cell immunostained for cell-surface markers followed by fixation, permeabilization and intracellular immunostaining" . This approach would be applicable when combining SPCC757.11c detection with other markers.

How does epitope selection impact the utility of SPCC757.11c antibodies in different experimental applications?

Epitope selection is critical for antibody functionality across different applications. While direct information about SPCC757.11c epitopes is not available in the search results, lessons from other antibody development efforts suggest:

  • Linear epitopes are generally more suitable for denatured applications (Western blot)

  • Conformational epitopes may better preserve native protein recognition (immunoprecipitation, flow cytometry)

  • Surface-exposed regions should be targeted for live-cell applications

The extensive validation process described for other antibodies demonstrates that verification across multiple applications is essential: "Extracellular, intracellular, single, and multicolour immunolabeling reactions and FACS analyses were all performed" . This multi-platform validation approach should be applied to SPCC757.11c antibodies as well.

What strategies can resolve inconsistent results when using SPCC757.11c antibodies across different experimental platforms?

When encountering inconsistent results with SPCC757.11c antibodies across platforms like Western blot, immunoprecipitation, and immunofluorescence, researchers should:

  • Assess buffer compatibility (detergents, salts, pH conditions may affect epitope accessibility)

  • Evaluate fixation effects (paraformaldehyde versus methanol fixation can yield different results)

  • Compare fresh versus frozen samples (protein degradation may affect results)

  • Examine epitope masking through protein interactions or post-translational modifications

  • Consider protein expression levels and detection sensitivity thresholds

For example, the differential detection of PM/Scl-75 and PM/Scl-100 antibodies highlighted in search result demonstrates how antigen expression systems can impact detection: "When the PM/Scl-100 antigen expressed by baculovirus was used, only 11 patients (3.9%) showed reactivity" compared to higher detection rates with E. coli-expressed antigen .

How can researchers determine the optimal concentration of SPCC757.11c antibodies for different experimental contexts?

Optimization of antibody concentration requires systematic titration across different applications:

  • Start with manufacturer recommendations if available

  • Perform dilution series experiments (typically 1:100 to 1:10,000 for primary antibodies)

  • Evaluate signal-to-noise ratio at each concentration

  • Consider blocking reagent optimization in parallel

  • Test multiple incubation times and temperatures

For flow cytometry applications, following protocols similar to those described in search result : "cells were labeled for 30 minutes with hybridoma supernatants or purified mAbs... followed by washing in FACS buffer and incubation for 30 minutes with conjugated fluorophore isotype matched secondary antibodies" .

What are the key differences between polyclonal and monoclonal SPCC757.11c antibodies for research applications?

Based on general antibody principles and information from the search results about other antibodies:

FeaturePolyclonal SPCC757.11c AntibodiesMonoclonal SPCC757.11c Antibodies
Epitope recognitionMultiple epitopesSingle epitope
Batch-to-batch variabilityHigherLower
Signal amplificationOften stronger due to multiple binding sitesMay require signal enhancement
Cross-reactivityPotentially higherGenerally more specific
Cost and productionUsually less expensive to produceHigher development costs
Best applicationsWestern blot, immunoprecipitationFlow cytometry, highly specific assays

As noted in search result , monoclonal antibodies offer particular advantages for specific applications: "These antibodies are significant because they enable new explorations... The antibodies should be useful for gaining a better understanding... enriching for... cells, removing... cells, and also for performing similar functions with subsets" .

What fixation and permeabilization protocols are optimal for SPCC757.11c detection in immunofluorescence?

While specific protocols for SPCC757.11c are not detailed in the search results, methodological approaches for similar applications suggest:

  • For membrane or surface proteins: 2-4% paraformaldehyde (10-15 minutes) with gentle permeabilization (0.1% Triton X-100 or 0.1% saponin)

  • For intracellular proteins: Consider methanol fixation (100%, -20°C, 10 minutes) which simultaneously fixes and permeabilizes

  • For dual detection of surface and intracellular markers: "cells were sequentially live cell immunostained for cell-surface markers followed by fixation, permeabilization and intracellular immunostaining"

Optimization may be necessary depending on the cellular localization of SPCC757.11c and the preservation of its epitopes under different fixation conditions.

How should researchers troubleshoot high background when using SPCC757.11c antibodies?

High background with SPCC757.11c antibodies may be addressed through:

  • Increasing blocking stringency (5-10% serum, milk, or BSA; "5% v/v ultrapurified BSA in Hank's Buffered Saline Solution" )

  • Reducing primary antibody concentration

  • Adding detergents to wash buffers (0.05-0.1% Tween-20)

  • Extending wash steps (3-5 washes of 5-10 minutes each)

  • Testing different blocking reagents (BSA vs. serum vs. commercial blockers)

  • Using fragment-specific secondary antibodies to reduce Fc receptor binding

From the methodology in search result , consider buffer modifications: "for the first step biotinylated UEA-I labeling, the FACS buffer was replaced with a 5% v/v ultrapurified BSA in Hank's Buffered Saline Solution (HBSS)... for all wash steps and for diluting the streptavidin fluorophore to avoid potential reactivity" .

How can SPCC757.11c antibodies be used to study protein-protein interactions in fission yeast?

For investigating protein-protein interactions involving SPCC757.11c, researchers should consider:

  • Co-immunoprecipitation coupled with mass spectrometry

  • Proximity ligation assays for in situ detection of interactions

  • FRET or BRET analysis for dynamic interaction studies

  • Chromatin immunoprecipitation (ChIP) if involved in transcriptional complexes

  • Yeast two-hybrid screening with SPCC757.11c as bait

Similar approaches have been successfully used with other yeast proteins: "Atf1 and Pcr1 associate with the promoters and coding regions of target genes in response to this carbon source change" , demonstrating how transcription factors can be studied through their DNA interactions.

What quantitative analysis methods are most appropriate for SPCC757.11c localization studies?

For quantitative analysis of SPCC757.11c localization:

  • Use automated image analysis software (ImageJ/FIJI, CellProfiler) for unbiased quantification

  • Implement colocalization analysis with known organelle markers (Pearson's or Mander's coefficient)

  • Consider FRAP (Fluorescence Recovery After Photobleaching) for dynamics studies

  • Use line scan analysis for distribution patterns across cellular compartments

  • Implement machine learning approaches for pattern recognition in complex images

Similar to the multi-parameter analysis described for other cellular studies: "Extracellular, intracellular, single, and multicolour immunolabeling reactions and FACS analyses were all performed" .

How can researchers assess SPCC757.11c expression changes across different growth conditions?

To analyze SPCC757.11c expression changes:

  • Combine immunoblotting with densitometry for semi-quantitative analysis

  • Use flow cytometry for single-cell quantification of expression levels

  • Implement RT-qPCR to correlate protein expression with transcript levels

  • Consider proteomics approaches for global protein changes

  • Use time-course experiments with synchronized cultures

The approach should be similar to that described for analyzing expression changes in other yeast proteins: "Atf1 and Pcr1 induce transcription of agl1 when the carbon source is switched from glucose to maltose" . This demonstrates how environmental conditions can influence gene expression, requiring appropriate experimental design to capture these changes.

What quality control parameters should researchers verify when selecting SPCC757.11c antibodies?

When selecting SPCC757.11c antibodies, researchers should verify:

  • Validation method documentation (Western blot, IP, IF, FACS)

  • Specificity testing (knockout/knockdown validation)

  • Cross-reactivity testing with related proteins

  • Lot-to-lot consistency data

  • Application-specific performance metrics

Quality control approaches similar to those used for other antibodies include extensive validation: "the LIA was subjected to an extensive validation process" including testing against sera from patients and controls .

How do storage and handling conditions affect SPCC757.11c antibody performance?

Based on general antibody principles:

  • Aliquot antibodies upon receipt to minimize freeze-thaw cycles

  • Store according to manufacturer recommendations (typically -20°C or -80°C for long-term)

  • Add preservatives (0.02% sodium azide) for working dilutions stored at 4°C

  • Monitor for signs of aggregation or precipitation

  • Test performance of older antibody lots against fresh lots periodically

While no specific storage information for SPCC757.11c antibodies is provided in the search results, these general principles apply to maintain optimal antibody performance.

What is the expected cross-reactivity profile of SPCC757.11c antibodies with proteins from other species?

Cross-reactivity expectations would depend on sequence conservation:

  • High conservation with other Schizosaccharomyces species (S. japonicus, S. octosporus)

  • Possible cross-reactivity with orthologous proteins in related yeasts

  • Limited cross-reactivity with mammalian proteins unless targeting highly conserved domains

Although specific cross-reactivity data for SPCC757.11c antibodies is not available in the search results, researchers should examine sequence homology and validate cross-reactivity experimentally before using these antibodies across species.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.